Image

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Recruiting
26 years and younger
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)
Print
Study details
    Connective and Soft Tissue Neoplasm
    Solid Tumors
    Malignant neoplasm of kidney
    kidney cancer
    Rhabdoid Tumor
    Hepatoblastoma
    Hepatoblastoma
    Carcinoma
    vulvar dysplasia and carcinoma
    Ewing's sarcoma
    Osteosarcoma
    Osteosarcoma
    Nerve Sheath Tumors
    melanoma
    Metastatic Melanoma
    melanoma
    Hereditary Neoplastic Syndrome
    hereditary cancer syndromes
    skin cancer
    skin cancer
    Desmoplastic Small Round Cell Tumor
    synovial sarcoma
    Nephroblastoma
    Rhabdomyosarcoma
    Rhabdomyosarcoma
    Clear cell sarcoma
    Retinoblastoma
    Retinoblastoma
    Neuroblastoma
    Neuroblastoma
    Sarcoma
    Sarcoma
    Germ cell tumor
    Metastatic Melanoma
    Pediatric Solid Tumor
    Solid Tumors
    vulvar dysplasia and carcinoma
    kidney cancer
    hereditary cancer syndromes

NCT04483778

Seattle Children's Hospital

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.